• 基因體研究中心二十週年活動

    基因體研究中心20歲了!為慶祝這具有里程碑意義的時刻,本中心於113年12月11日(三)舉辦20週年慶祝活動。感謝歷屆中心成員、合作夥伴及各界貴賓的參與,共同見證中心的成長與茁壯。 Read More
  • 陳韻如老師研究團隊榮獲2024國家新創精進獎

    神經退化性疾病藥物大多是減緩症狀而無針對致病標的。本團隊的新創研發抗體藥物會專一辨認錯誤折疊的TDP-43寡聚體(oligomer),不會辨認正常的TDP-43。研究證實誤折疊的TDP-43寡聚體具有神經毒性,並存在於... Read More
  • 精準化學修飾新篇章 從天然物啟發到高效罕病藥物開發

    「天然ㄟ尚好!」科學家過去從天然物中分離出許多具有初步生物活性的小分子,然而這些分子往往需要透過化學改良和修飾(chemical modification)方能發揮其潛力。本中心鄭偉杰實驗室經由精準化學修飾策略,優化分子結構,發現一種新型藥理伴護小分子... Read More
  • 恭賀本中心洪上程特聘研究員當選中央研究院第34屆新科院士

    中央研究院第34屆院士暨名譽院士名單揭曉,由廖俊智院長與院士會議四組召集人於今(4)日會後記者會中共同宣布選舉結果,本中心洪上程特聘研究員當選中央研究院第34屆院士,恭喜洪老師! Read More
  • 硫酸雙醣分子可修復蛋白質增益毒性 漸凍人治療新思路

    ALS與FTD這兩種疾病在臨床表現上有所不同,卻共享相當多的病理特徵和基因變異。在家族性遺傳患者上,這兩種疾病最常見的基因突變皆來自位於C9ORF72基因非編碼區域中DNA重複擴增GGGGCC (G4C2) 序列的突變,容易觸發「非傳統ATG啟動子」(non-ATG-initiated translation)的蛋白轉譯機制(RAN)作用... Read More
  • 陳緯助研究員獲選代表本院出席日本科技與社會論壇(STS Forum)及其青年領袖計畫

    本中心陳緯老師致力於奈米生物醫學,生醫材料與藥物輸送技術等相關研究,且在研究領域擔任領導角色與具備優秀的英文能力,獲得本院肯定,獲選出席日本科技與社會論壇(STS Forum)及其青年領袖計畫。 Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

Language

獲獎與人事消息

  • 恭喜阮麗蓉老師實驗室周建德博士與博士班學生林怡斈獲得第30屆細胞及分子生物新知研討會暨30屆慶祝活動之騰達行優秀壁報論文獎的第三名與佳作
    Read More
  • 恭喜胡春美老師實驗室吳丹霓小姐獲得114年度國際研究生學程博士生「研究進步獎學金」
    Read More
  • 113年度研究績優人員表揚
    Read More
  • 恭喜陳韻如老師實驗室蔡天穎博士獲得2024年永信李天德醫藥基金會壁報論文特優獎
    Read More

研究分享系列

  • All
  • 研究消息
  • 科普演講
load more hold SHIFT key to load all load all

Chen, Ding-Shinn 陳定信

DSChen6x7客座講座


Email: Email住址會使用灌水程式保護機制。你需要啟動Javascript才能觀看它
 



EDUCATION AND POSITIONS HELD:

  • MD, National Taiwan University School of Medicine, 1968
  • Resident, Department of Internal Medicine, National Taiwan University Hospital, 1969-73
  • Associate Professor, National Taiwan University College of Medicine, Taipei, Taiwan, 1978-83
  • Visiting Scientist, National Institutes of Health, Bethesda, USA, 1979-80
  • Professor of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan, 1983-2013
  • Founding Director, Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan, 1987-2001
  • Dean, National Taiwan University College of Medicine, Taipei, Taiwan, 2001-2007

HONORS:

  • National Outstanding Science and Technology Award of the Republic of China, Executive Yuan, Taiwan, 1984
  • Abbott Laboratories Research Award, Abbott Laboratories, USA, 1986
  • Outstanding Research Award in Biology and Medicine, National Science Council, Taiwan, 1987-1993
  • Outstanding Academic Award (Medicine), Ministry of Education, Taiwan, 1989
  • Academician, Academia Sinica, Taiwan, 1992
  • Grand Award, Society of Chinese Bioscientists in America (SCBA), USA, 1993
  • Hou Jin-Duei Outstanding Contribution Award in Basic Science, Taiwan, 1994
  • Outstanding Scholar Award, Foundation for the Advancement of Outstanding Scholarship, Taiwan, 1995-1999
  • National Chair-Professor of Medicine, Ministry of Education, Taiwan, 1997-2003
  • Lifetime National Chair-Professor of Medicine, Ministry of Education, Taiwan, 2004
  • Fellow, The Third World Academy of Sciences (TWAS), Italy, 2001
  • Doctor of Philosophy (honoris causa), Kaohsiung Medical University, Taiwan, 2002
  • Foreign Associate, National Academy of Sciences, USA, 2005
  • Caring Physicians of the World, World Medical Association, France, 2005
  • Outstanding Achievement Award, Foundation for the Advancement of Outstanding Scholarship, Taiwan, 2005
  • Trieste Science Prize, TWAS, Italy, 2006
  • Presidential Science Prize of Taiwan, Taiwan, 2007
  • EASL International Recognition Award, Denmark, 2009
  • Okuda Lectureship Award, JGH Foundation, Australia, 2009
  • Nikkei Asia Prize, Japan, 2010
  • Distinguished Clinician Educator/Mentor Award, AASLD, San Francisco, 2011
  • President’s Award, Chung-Hwa Rotary Educational Foundation, Taichung, 2014
  • Doctor of Philosophy (honoris causa), China Medical University, Taichung, 2014
  • TASL Mentor Award, Taiwan Association for the Study of the Liver, Taiwan, 2015
  • First Rank Health & Welfare Medal, Ministry of Health and Welfare, Taiwan, 2015

RESEARCH INTERESTS:

Dr. Chen’s research interest continues to be in the basic and clinical aspects of viral hepatitis and liver disease, ranging from prevention to management.

In the last 40 years, although he and his colleagues have solved many problems of liver disease in Taiwan, there are still a lot of unresolved issues. They will continue to address these issues in chronic hepatitis B infection and its implications (Science 1993; 262:369-70). In addition, chronic hepatitis C will be another important topic.

Dr. Chen’s current major efforts are to explore these issues by using a mouse-model of chronic hepatitis B virus (HBV) infection his team has established before (PNAS 2006; 103:17862-7). With this animal model, they hope to explore the mechanism of persistent hepatitis B infection, e. g., why is the infection associated with chronicity especially in young age, the genetic and immunologic background of persistent infection, etc. Preliminary results showed that HBV persistence was closely related to the establishment of gut microbiota, and TLR4 played a critical role (PNAS 2015; 112:2175-80). They will further dissect the mechanism of HBV persistence focusing on the roles of Kupffer cells in the innate immunity against HBV as well as the natural killer cells and other immune cells in breaking the tolerance to HBV persistence. These results may disclose novel immunologic mechanisms of HBV persistence and then provide new targets for futher effective therapy. The results will hopefully be translated to clinical settings in humans.

DSChenFig3

As a clinician, Dr. Chen still keeps translational and clinical research on chronic hepatitis B and C as well as liver cirrhosis and hepatocellular carcinoma. His academic achievements can be seen from his publications as shown in PubMed.

Intranet Icon ch

EmploymentIcon ch

Subsitute Service ch

eln grcweb

Ed sideMenu CH

GRC ES

研之有物 sidemenu

演講及活動

目前暫無活動

calendar

ASWeb Icon